-ATX-01 is the industry’s first microRNA therapeutic to be evaluated for DM1 and the first program from ARTHEX’s pipeline to enter the clinic – -First patient expected to be enrolled in Q2 2024- VALENCIA, Spain, Feb. 28, 2024 /PRNewswire/ — ARTHEx Biotech S.L., a clinical-stage…

STOCKHOLM, Feb. 28, 2024 /PRNewswire/ — Hygiene and health company Essity is today publishing its Annual Report for 2023 on essity.com. “We leave an eventful year behind us in which we have focused on increasing profitability and created a stable platform for profitable growth. Through…

STOCKHOLM, Feb. 28, 2024 /PRNewswire/ — Hygiene and health company Essity is today publishing its Annual Report for 2023 on essity.com. “We leave an eventful year behind us in which we have focused on increasing profitability and created a stable platform for profitable growth. Through…

Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.